Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice

Abstract Human malaria affects the vast majority of the world’s population with the Plasmodium falciparum species causing the highest rates of morbidity and mortality. With no licensed vaccine and leading candidates achieving suboptimal protection in the field, the need for an effective immunoprophy...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Katherine L. Mallory, Justin A. Taylor, Xiaoyan Zou, Ishita N. Waghela, Cosette G. Schneider, Michael Q. Sibilo, Neeraja M. Punde, Leah C. Perazzo, Tatyana Savransky, Martha Sedegah, Sheetij Dutta, Chris J. Janse, Norbert Pardi, Paulo J. C. Lin, Ying K. Tam, Drew Weissman, Evelina Angov
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/e05bb1dcc8a24bf8950c79ee7ff517fc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e05bb1dcc8a24bf8950c79ee7ff517fc
record_format dspace
spelling oai:doaj.org-article:e05bb1dcc8a24bf8950c79ee7ff517fc2021-12-02T16:04:30ZMessenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice10.1038/s41541-021-00345-02059-0105https://doaj.org/article/e05bb1dcc8a24bf8950c79ee7ff517fc2021-06-01T00:00:00Zhttps://doi.org/10.1038/s41541-021-00345-0https://doaj.org/toc/2059-0105Abstract Human malaria affects the vast majority of the world’s population with the Plasmodium falciparum species causing the highest rates of morbidity and mortality. With no licensed vaccine and leading candidates achieving suboptimal protection in the field, the need for an effective immunoprophylactic option continues to motivate the malaria research community to explore alternative technologies. Recent advances in the mRNA discipline have elevated the long-neglected platform to the forefront of infectious disease research. As the immunodominant coat protein of the invasive stage of the malaria parasite, circumsporozoite protein (PfCSP) was selected as the antigen of choice to assess the immunogenic and protective potential of an mRNA malaria vaccine. In mammalian cell transfection experiments, PfCSP mRNA was well expressed and cell associated. In the transition to an in vivo murine model, lipid nanoparticle (LNP) encapsulation was applied to protect and deliver the mRNA to the cell translation machinery and supply adjuvant activity. The immunogenic effect of an array of factors was explored, such as formulation, dose, number, and interval of immunizations. PfCSP mRNA-LNP achieved sterile protection against infection with two P. berghei PfCSP transgenic parasite strains, with mRNA dose and vaccination interval having a greater effect on outcome. This investigation serves as the assessment of pre-erythrocytic malaria, PfCSP mRNA vaccine candidate resulting in sterile protection, with numerous factors affecting protective efficacy, making it a compelling candidate for further investigation.Katherine L. MalloryJustin A. TaylorXiaoyan ZouIshita N. WaghelaCosette G. SchneiderMichael Q. SibiloNeeraja M. PundeLeah C. PerazzoTatyana SavranskyMartha SedegahSheetij DuttaChris J. JanseNorbert PardiPaulo J. C. LinYing K. TamDrew WeissmanEvelina AngovNature PortfolioarticleImmunologic diseases. AllergyRC581-607Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Vaccines, Vol 6, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Katherine L. Mallory
Justin A. Taylor
Xiaoyan Zou
Ishita N. Waghela
Cosette G. Schneider
Michael Q. Sibilo
Neeraja M. Punde
Leah C. Perazzo
Tatyana Savransky
Martha Sedegah
Sheetij Dutta
Chris J. Janse
Norbert Pardi
Paulo J. C. Lin
Ying K. Tam
Drew Weissman
Evelina Angov
Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
description Abstract Human malaria affects the vast majority of the world’s population with the Plasmodium falciparum species causing the highest rates of morbidity and mortality. With no licensed vaccine and leading candidates achieving suboptimal protection in the field, the need for an effective immunoprophylactic option continues to motivate the malaria research community to explore alternative technologies. Recent advances in the mRNA discipline have elevated the long-neglected platform to the forefront of infectious disease research. As the immunodominant coat protein of the invasive stage of the malaria parasite, circumsporozoite protein (PfCSP) was selected as the antigen of choice to assess the immunogenic and protective potential of an mRNA malaria vaccine. In mammalian cell transfection experiments, PfCSP mRNA was well expressed and cell associated. In the transition to an in vivo murine model, lipid nanoparticle (LNP) encapsulation was applied to protect and deliver the mRNA to the cell translation machinery and supply adjuvant activity. The immunogenic effect of an array of factors was explored, such as formulation, dose, number, and interval of immunizations. PfCSP mRNA-LNP achieved sterile protection against infection with two P. berghei PfCSP transgenic parasite strains, with mRNA dose and vaccination interval having a greater effect on outcome. This investigation serves as the assessment of pre-erythrocytic malaria, PfCSP mRNA vaccine candidate resulting in sterile protection, with numerous factors affecting protective efficacy, making it a compelling candidate for further investigation.
format article
author Katherine L. Mallory
Justin A. Taylor
Xiaoyan Zou
Ishita N. Waghela
Cosette G. Schneider
Michael Q. Sibilo
Neeraja M. Punde
Leah C. Perazzo
Tatyana Savransky
Martha Sedegah
Sheetij Dutta
Chris J. Janse
Norbert Pardi
Paulo J. C. Lin
Ying K. Tam
Drew Weissman
Evelina Angov
author_facet Katherine L. Mallory
Justin A. Taylor
Xiaoyan Zou
Ishita N. Waghela
Cosette G. Schneider
Michael Q. Sibilo
Neeraja M. Punde
Leah C. Perazzo
Tatyana Savransky
Martha Sedegah
Sheetij Dutta
Chris J. Janse
Norbert Pardi
Paulo J. C. Lin
Ying K. Tam
Drew Weissman
Evelina Angov
author_sort Katherine L. Mallory
title Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
title_short Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
title_full Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
title_fullStr Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
title_full_unstemmed Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
title_sort messenger rna expressing pfcsp induces functional, protective immune responses against malaria in mice
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/e05bb1dcc8a24bf8950c79ee7ff517fc
work_keys_str_mv AT katherinelmallory messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice
AT justinataylor messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice
AT xiaoyanzou messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice
AT ishitanwaghela messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice
AT cosettegschneider messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice
AT michaelqsibilo messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice
AT neerajampunde messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice
AT leahcperazzo messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice
AT tatyanasavransky messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice
AT marthasedegah messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice
AT sheetijdutta messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice
AT chrisjjanse messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice
AT norbertpardi messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice
AT paulojclin messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice
AT yingktam messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice
AT drewweissman messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice
AT evelinaangov messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice
_version_ 1718385239548493824